Executive summary of the 12th HHT international scientific conference

被引：0

作者：

Jillian W. Andrejecsk

Anna E. Hosman

Luisa M. Botella

Claire L. Shovlin

Helen M. Arthur

Sophie Dupuis-Girod

Elisabetta Buscarini

Christopher C. W. Hughes

Franck Lebrin

Christine L. Mummery

Marco C. Post

Johannes J. Mager

机构：

[1] University of California Irvine,Department of Molecular Biology and Biochemistry

[2] St. Antonius Hospital,Department of Pulmonology

[3] Centro de Investigaciones Biológicas,Vascular Science, National Heart and Lung Institute

[4] Consejo Superior de Investigaciones Científicas (CSIC),Institute of Genetic Medicine, Centre for Life

[5] and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER),Gastroenterology and Endoscopy Department, Reference Center for Hereditary Hemorrhagic Telangiectasia

[6] Imperial College London,Einthoven Laboratory for Experimental Vascular Medicine, Department of Internal Medicine (Nephrology)

[7] Newcastle University,Department of Anatomy and Embryology

[8] Hospices Civils de Lyon,Department of Cardiology

[9] Genetic Unit and HHT Reference Center,undefined

[10] Bron,undefined

[11] School of Medical and University Lyon 1,undefined

[12] Maggiore Hospital,undefined

[13] ASST Crema,undefined

[14] Leiden University Medical Center,undefined

[15] CNRS UMR 7587,undefined

[16] INSERM U979,undefined

[17] Institut Langevin,undefined

[18] ESPCI,undefined

[19] Leiden University Medical Center,undefined

[20] St. Antonius Hospital,undefined

来源：

Angiogenesis | 2018年 / 21卷

关键词：

HHT; Hereditary hemorrhagic telangiectasia; Endoglin; Activin receptor-like kinase 1 (ALK1); Arteriovenous malformation; Epistaxis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Hereditary hemorrhagic telangiectasia is an autosomal dominant trait affecting approximately 1 in 5000 people. A pathogenic DNA sequence variant in the ENG, ACVRL1 or SMAD4 genes, can be found in the majority of patients. The 12th International Scientific HHT Conference was held on June 8–11, 2017 in Dubrovnik, Croatia to present and discuss the latest scientific achievements, and was attended by over 200 scientific and clinical researchers. In total 174 abstracts were accepted of which 58 were selected for oral presentations. This article covers the basic science and clinical talks, and discussions from three theme-based workshops. We focus on significant emergent themes and unanswered questions. Understanding these topics and answering these questions will help to define the future of HHT research and therapeutics, and ultimately bring us closer to a cure.

引用

页码：169 / 181

页数：12

共 5 条

[1] Executive summary of the 12th HHT international scientific conference
Andrejecsk, Jillian W.
Hosman, Anna E.
Botella, Luisa M.
Shovlin, Claire L.
Arthur, Helen M.
Dupuis-Girod, Sophie
Buscarini, Elisabetta
Hughes, Christopher C. W.
Lebrin, Franck
Mummery, Christine L.
Post, Marco C.
Mager, Johannes J.
ANGIOGENESIS, 2018, 21 (01) : 169 - 181
[2] Executive summary of the 11th HHT international scientific conference
Helen Arthur
Urban Geisthoff
James R. Gossage
Christopher C. W. Hughes
Pascal Lacombe
Mary E. Meek
Paul Oh
Beth L. Roman
Scott O. Trerotola
Sebastiaan Velthuis
Whitney Wooderchak-Donahue
Angiogenesis, 2015, 18 : 511 - 524
[3] Executive summary of the 11th HHT international scientific conference
Arthur, Helen
Geisthoff, Urban
Gossage, James R.
Hughes, Christopher C. W.
Lacombe, Pascal
Meek, Mary E.
Oh, Paul
Roman, Beth L.
Trerotola, Scott O.
Velthuis, Sebastiaan
Wooderchak-Donahue, Whitney
ANGIOGENESIS, 2015, 18 (04) : 511 - 524
[4] Executive summary of the 14th HHT international scientific conference
Ola, Roxana
Hessels, Josefien
Hammill, Adrienne
Friday, Cassi
Clancy, Marianne
Al-Samkari, Hanny
Meadows, Stryder
Iyer, Vivek
Akhurst, Rosemary
ANGIOGENESIS, 2023, 26 (01) : S27 - S37
[5] Executive summary of the 14th HHT international scientific conference
Ola R.
Hessels J.
Hammill A.
Friday C.
Clancy M.
Al-Samkari H.
Meadows S.
Iyer V.
Akhurst R.
Angiogenesis, 2023, 26 (Suppl 1) : 27 - 37

← 1 →